Showing results (91-100 of 124) with videos related to
Sort By:
Pageof 13
Journal of Biotechnology|May 10, 2015
Quantification of cell lysis during CHO bioprocesses: Impact on cell count, growth kinetics and productivityTobias Klein, Nicole Heinzel, Paul Kroll, et al.Journal of Medical Economics|January 19, 2021
Societal costs of primary progressive multiple sclerosis in Australia and the economic impact of a hypothetical disease-modifying treatment that could delay disease progressionLaurie J Brown, Jinjing Li, Matthias Brunner, et al.Human Vaccines|October 16, 2009
Economic evaluation of varicella vaccination in Swiss children and adolescentsKurt Banz, Andrea Iseli, Christoph Aebi, et al.Human Vaccines|October 16, 2009
Prospective surveillance of varicella-zoster virus infections in an out-patient setting in SwitzerlandAndrea Iseli, Christoph Aebi, Kurt Banz, et al.Environmental Toxicology and Chemistry|November 4, 2014
Environmental fate of emamectin benzoate after tree micro injection of horse chestnut treesRene Burkhard, Heinz Binz, Christian A Roux, et al.Translational Vision Science & Technology|October 4, 2018
Functional Staging of Corneal Neovascularization Using Fluorescein and Indocyanine Green AngiographyChristoph Palme, Vito Romano, Matthias Brunner, et al.Journal of Chemical Technology and Biotechnology (Oxford, Oxfordshire : 1986)|August 3, 2018
Media photo-degradation in pharmaceutical biotechnology - impact of ambient light on media quality, cell physiology, and IgG production in CHO culturesLukas Neutsch, Paul Kroll, Matthias Brunner, et al.Cornea|May 6, 2016
Method for Angiographically Guided Fine-Needle Diathermy in the Treatment of Corneal NeovascularizationVito Romano, Bernhard Steger, Matthias Brunner, et al.Biotechnology Journal|January 13, 2017
The impact of pH inhomogeneities on CHO cell physiology and fed-batch process performance - two-compartment scale-down modelling and intracellular pH excursionMatthias Brunner, Philipp Braun, Philipp Doppler, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|September 16, 2020
The societal burden of haemophilia A. II - The cost of moderate and severe haemophilia A in AustraliaLaurie J Brown, Hai A La, Jinjing Li, et al.Pageof 13